Abstract
Background: Obesity is a worldwide pandemic and one of the most serious public health issues and causes a lot of complications to obese patients as gastroesophageal reflux disease (GERD). Bariatric surgery proves more effectiveness for morbid obese patients to lose weight and is demonstrated to include significant and long term remission of obesity related comorbidities. Methods: This a controlled clinical trial study involved 50 patients, who are diagnosed as a morbidly obese patients with GERD grade(A) and (B) by endoscopy according to their BMI (>40) or >35 with one or two of obesity related co-morbidities such as diabetes mellitus. Patients were divided into 2 groups, group (A) (25 patients) underwent LSG with cruroplasty, and group (B) (25 patients) underwent LRYGB. Results: There was no statistically significant difference found between the two studied groups regarding EBW loss percentage at 1 month while there was statistically significant increase in the EBW loss percentage at 3 months, 6 months and at 1 year in LRYGB group than LSG with cururoplasty group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
